Adjunctive Ziprasidone in overweight and obese patients with bipolar disorder
Phase of Trial: Phase IV
Latest Information Update: 12 May 2017
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions
- 01 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Mar 2008 Status change from recruiting to in progress.
- 21 May 2007 New trial record.